Noida, UP -- (ReleaseWire) -- 02/06/2014 -- The diabetes drug market of China is growing rapidly owing to various factors including increasing ageing population, obesity rates and change in lifestyle habits throughout the country. According to IDF data, approximately 92 Million people are suffering from diabetes in China, nearly 40% are undiagnosed. Diabetic patient potential in China would increase to approximately 130 Million by 2030. Even country’s government is actively spending money over the purchase of diabetes drugs which in turn would increase the overall market for diabetes drugs. Meanwhile several awareness programs throughout the country are subsequently boosting the sales of diabetes drugs.
However, the market is subsequently crowded with advanced drugs as well as insulin delivery devices. Even the big pharmaceutical companies are looking for opportunity in this potential market through the launch of new diabetes drug compositions and insulin delivery devices. Market players keep on increasing their product portfolios to gain prospective share in the market.
Research Analysis & Highlights
The report entitled “China Diabetes Market Outlook 2018”, provides an extensive research and in-depth analysis of the segmentation of diabetes market into oral diabetic drug market, insulin drug market, insulin delivery devices market, and glucose monitoring market. The research covers the market for each segment along with their current and future projections. Our study moreover evaluates the socioeconomic growth pattern throughout the country. It provides an overview of the patient affordability factor, disease prevalence rate and healthcare expenditure on diabetes. The report also discusses the regulatory landscape for diabetes market and current trends and drivers. Moreover, it provides an exhaustive study of the key players with their recent developments and product portfolios. Overall the report is an effective description of China Diabetes Market and will provide the client a source of knowledge and insights on same.
Some of the key findings of the report:
- Increasing effort by pharmaceutical players to tap the potential diabetes market in China
- Technological advancement in insulin delivery devices driving the market
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM648.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.